TrialBritish journal of cancer2014

Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed.

J-L Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.